Regenerative Engineering and Translational Medicine

Congratulations to Editor-in-Chief Professor Sir Cato T. Laurencin on receiving the 2026 Jensen Tissue Engineering Award, the highest honor of the Tissue Engineering and Regenerative Medicine International Society (TERMIS)! This award recognizes Dr. Laurencin’s contributions in the field of tissue engineering and regenerative medicine and affirms the distinctiveness of the vision, mission and purpose of the field of Regenerative Engineering. He will be receiving this distinction in November at the TERMIS-AM conference. Please join us in congratulating him. 

Regenerative Engineering and Translational Medicine is proud to welcome Dr. Edward A. Botchwey to the board as Assistant Managing Editor!

Regenerative Engineering and Translational Medicine is the leading journal in the field covering convergence research in regeneration.

• The premier forum for research in advanced materials science, stem cells science, biophysics, developmental biology, and clinical translation for regeneration.
• A Journal for engineers, scientists, clinicians and lay people, with a lay abstract included for every paper.
• Highlights convergence research in pre-clinical, translational and clinical phases.
• A high profile Springer Nature journal and the official journal of the Regenerative Engineering Society.

Editor-in-Chief

• Cato T. Laurencin MD, PhD

Journal Impact Factor

1.9 (2024)

5-year Journal Impact Factor

2.5 (2024)

Submission to first decision (median)

9 days

Downloads

136.7k (2025)